serena williams on glp 1 Why She Chose to Use GLP-1 Medication What Serena Williams' GLP-1 Story

In a small open-label trial of exenatide in people with clozapine-associated obesity (BMI 3045 kg/m 2 ), those on exenatide had about 10 pounds more weight loss than placebo at 24 weeks (Siskind D et al, J Psychiatr Res 2020;124:912)

One key ingredient in this blend is the 250 mg of L-Theanine, which is an ingredient known to support mood and help manage stress, which makes it an important facto

STORAGE Lyophilized 4 C 24 months protected from light Reconstituted 28 C, 14 days protected from light (faster degradation than non-copper peptides) PEER-REVIEWED EVIDENCE Pickart L

Because weight management is Foundayo s only approved use right now, the Bridge is effectively the one way Medicare covers it, which makes timing matter